NARA Discovery
Article Details
← Back to Search Results
Journal Article

Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis

Rui Lu; Zhiyong Li; Shucheng Yin
Biochemical Genetics · Vol. 60, Issue 5 · pp. 1825-1844 · 2022

Abstract

Ferroptosis is a novel discovered iron-dependent mode of regulated cell death (RCD) which characterized non-apoptosis. Researches have shown the effect of ferroptosis in the biological activities of tumors. But there is no relevant study showing the relationship between ferroptosis-related genes and head and neck squamous cell carcinoma (HNSCC). In this study, we paid attention to several ferroptosis-related lncRNAs in head and neck squamous cell carcinoma and its clinical features. HNSCC data were obtained from The Cancer Genome Atlas (TCGA) database. Ferroptosis-related lncRNAs were selected by the coexpression network. Then, we identified prognostic ferroptosis-related lncRNAs in HNSCC patients and constructed a ferroptosis-related lncRNAs signature by Lasso cox regression. Besides, GSEA analysis was performed to explore the functional enrichment of ferroptosis-related lncRNAs. Nine ferroptosis-related lncRNAs (AC004687.1, AL450992.2, AC010894.2, AL451085.2, AC104083.1, LIPE-AS1, AC108010.1, CTBP1-DT, and PTCSC2) were identified to have the independent prognostic value in HNSCC patients and the ferroptosis-related lncRNAs signature was constructed based on these nine genes. According to the risk score of the signature, the high-risk group had shorter overall survival (OS) compared with the low-risk group. Risk score showed to be an independent factor for the patients with HNSCC. Additionally, the nomogram was generated and the nine lncRNAs were mainly enriched in phagocytosis, metabolism, and chemokine signaling pathways. The ferroptosis-related lncRNA signature has effects on the prognostic prediction of patients with HNSCC which may serve as potential therapeutic targets for patients with HNSCC.

Bibliographic Information

JournalBiochemical Genetics
PublisherSpringer
Publication Date2022-10-01
Publication Year2022
Volume60
Issue5
Pages1825-1844
Document TypeJournal Article
Print ISSN0006-2928
eISSN1573-4927
DOI10.1007/s10528-021-10176-2

Access Information

NARA Access Coverage1967-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10528
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.